Translational Development Acquisition Corp. · NASDAQ:TDAC

Goldman Sachs Group Inc reported a 6.10% stake in Translational Development Acquisition Corp. (Schedule 13G)

Event Mar 31, 2026 · Filed May 13, 2026

Goldman Sachs Group Inc reported a 6.10% stake in Translational Development Acquisition Corp., 1,054,120 shares, as a passive investor on Mar 31, 2026. Filed May 13, 2026 (Schedule 13G).

Stake
6.10%
Shares
1,054,120
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.6.10%1,054,120
GOLDMAN SACHS & CO. LLC6.10%1,054,120

Source

View original at SEC

Related